Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DVD for Newly Diagnosed Multiple Myeloma
NCT00742404Phase 2Unknown
- Sponsor
- ONCOtherapeutics
- Start
- Jul 2008
- Primary completion
- Jul 2010
- Modality
- Modified Peptides, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin, bortezomib in multiple myeloma (MM), sponsored by ONCOtherapeutics. Status: unknown.
02
Drugs
doxorubicinbortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00742404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00742404.